EUVIMEDEUVIMED entdecken
Multizentrische StudieOpen Access · CC BY-NC 4.0

Real-World Data on the Efficacy and Safety of Fexuprazan in Patients with Gastroesophageal Reflux Disease: Interim Analysis of Post-Marketing Surveillance

Jie-Hyun Kim iD, Ki Hong Lee iD, Woo Seok Lee iD, Kyung Oh Kim iD, Jaehong Chun iD, Jae Won Seo iD, Seung Ho Choi iD, Hyeong Cheol Jeong iD, Yongmin Jo iD, Jae J Kim iD, Si Hyung Lee iD, Jeong Hyeon Cho iD und 3 weitere

Gut and Liver · 15.11.2026 · 20 (6) · 998-1005

DOI: 10.5009/gnl250427 ↗

Kurz gefasst

Multizentrische Studie in der Zeitschrift Gut and Liver, online erschienen am 10.06.2026. Verfasst von Jie-Hyun Kim und 14 weiteren Autor:innen. Beteiligte Einrichtung: Department of Internal Medicine, Gangnam Severance Hospital, Yonsei University College of Medicine, Seoul, Korea. Hauptthemen laut MEDLINE: Gastroesophageal Reflux, Gastrointestinal Agents. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 18 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Gastroesophageal RefluxGastrointestinal AgentsAdultAgedAged, 80 and overFemaleHumansMaleMiddle AgedProduct Surveillance, PostmarketingQuality of LifeRepublic of KoreaTreatment OutcomeAminesPyrroles

Stichwörter der Autor:innen

AgedFexuprazanGastroesophageal refluxPost-marketing surveillancePotassium-competitive acid blocker

Substanzen

fexuprazanGastrointestinal AgentsAminesPyrroles

Autor:innen und Institutionen

  • Department of Internal Medicine, Gangnam Severance Hospital, Yonsei University College of Medicine, Seoul, Korea.
  • Department of Cardiovascular Medicine, The Heart Center of Chonnam National University Hospital, Gwangju, Korea.
  • Yeosu Jeil Hospital, Yeosu, Korea.
  • Division of Gastroenterology and Hepatology, Department of Internal Medicine, Hallym University Medical Center, Seoul, Korea.
  • Haeundae Sharing and Happiness Hospital, Busan, Korea.
  • Naju General Hospital, Naju, Korea.

ORCID-Profile: Jie-Hyun Kim, Ki Hong Lee, Woo Seok Lee, Kyung Oh Kim, Jaehong Chun, Jae Won Seo, Seung Ho Choi, Hyeong Cheol Jeong, Yongmin Jo, Jae J Kim, Si Hyung Lee, Jeong Hyeon Cho, Hye Won Lee, Areum Lee, Moo In Park

Zitieren

APA

Kim, J. H., Lee, K. H., Lee, W. S., Kim, K. O., Chun, J., Seo, J. W., Choi, S. H., Jeong, H. C., Jo, Y., Kim, J. J., Lee, S. H., Cho, J. H., Lee, H. W., Lee, A., & Park, M. I. (2026). Real-World Data on the Efficacy and Safety of Fexuprazan in Patients with Gastroesophageal Reflux Disease: Interim Analysis of Post-Marketing Surveillance. Gut and Liver, 20(6), 998-1005. https://doi.org/10.5009/gnl250427

Vancouver

Kim JH, Lee KH, Lee WS, Kim KO, Chun J, Seo JW, et al. Real-World Data on the Efficacy and Safety of Fexuprazan in Patients with Gastroesophageal Reflux Disease: Interim Analysis of Post-Marketing Surveillance. Gut and Liver. 2026;20(6):998-1005. doi:10.5009/gnl250427

BibTeX
@article{Kim2026,
  author = {Kim, Jie-Hyun and Lee, Ki Hong and Lee, Woo Seok and Kim, Kyung Oh and Chun, Jaehong and Seo, Jae Won and Choi, Seung Ho and Jeong, Hyeong Cheol and Jo, Yongmin and Kim, Jae J and Lee, Si Hyung and Cho, Jeong Hyeon and Lee, Hye Won and Lee, Areum and Park, Moo In},
  title = {Real-World Data on the Efficacy and Safety of Fexuprazan in Patients with Gastroesophageal Reflux Disease: Interim Analysis of Post-Marketing Surveillance},
  journal = {Gut and Liver},
  year = {2026},
  volume = {20},
  number = {6},
  pages = {998--1005},
  doi = {10.5009/gnl250427}
}
Kostenlos starten →